ATE205190T1 - Vitamin d3-derivate und ein verfahren zu ihrer herstellung - Google Patents

Vitamin d3-derivate und ein verfahren zu ihrer herstellung

Info

Publication number
ATE205190T1
ATE205190T1 AT98101654T AT98101654T ATE205190T1 AT E205190 T1 ATE205190 T1 AT E205190T1 AT 98101654 T AT98101654 T AT 98101654T AT 98101654 T AT98101654 T AT 98101654T AT E205190 T1 ATE205190 T1 AT E205190T1
Authority
AT
Austria
Prior art keywords
sub
vitamin
derivatives
production
group
Prior art date
Application number
AT98101654T
Other languages
English (en)
Inventor
Masayasu C O Teijin Ltd Tabe
Atsuo C O Teijin Ltd Hazato
Kenji C O Teijin Ltd Manabe
Qingzhi C O Teijin Ltd Gao
Hiroko C O Teijin Ltd Tanaka
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of ATE205190T1 publication Critical patent/ATE205190T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AT98101654T 1994-06-07 1995-06-07 Vitamin d3-derivate und ein verfahren zu ihrer herstellung ATE205190T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP12514494 1994-06-07
JP22018594 1994-09-14
JP22322994 1994-09-19

Publications (1)

Publication Number Publication Date
ATE205190T1 true ATE205190T1 (de) 2001-09-15

Family

ID=27315056

Family Applications (3)

Application Number Title Priority Date Filing Date
AT98101653T ATE201397T1 (de) 1994-06-07 1995-06-07 Vitamin d3 derivate und ein verfahren zu ihrer herstellung
AT95921131T ATE186721T1 (de) 1994-06-07 1995-06-07 Vitamin d3 derivat und verfahren zu dessen herstellung
AT98101654T ATE205190T1 (de) 1994-06-07 1995-06-07 Vitamin d3-derivate und ein verfahren zu ihrer herstellung

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT98101653T ATE201397T1 (de) 1994-06-07 1995-06-07 Vitamin d3 derivate und ein verfahren zu ihrer herstellung
AT95921131T ATE186721T1 (de) 1994-06-07 1995-06-07 Vitamin d3 derivat und verfahren zu dessen herstellung

Country Status (6)

Country Link
US (3) US5719297A (de)
EP (3) EP0854139B1 (de)
AT (3) ATE201397T1 (de)
DE (3) DE69513367T2 (de)
ES (1) ES2138212T3 (de)
WO (1) WO1995033716A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854139B1 (de) * 1994-06-07 2001-09-05 Teijin Limited Vitamin D3-Derivate und ein Verfahren zu ihrer Herstellung
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
GB2321244B (en) * 1997-01-20 2000-11-22 Pharmacia & Upjohn Spa Vitamin D3 analogues,process for preparing them,and their use as antiproliferative and antitumour agents
CN1090180C (zh) * 1997-06-25 2002-09-04 帝人株式会社 维生素d3衍生物及其用于炎性呼吸道疾病的治疗剂
EP1123921A4 (de) 1998-10-23 2003-08-20 Teijin Ltd Vitamin d 3 derivate und diese enthaltende heilmittel für entzündliche erkrankungen der atemwege
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
US20020137731A1 (en) 2000-05-30 2002-09-26 Gewirtz David A. Combination of radiation and vitamin D3 analogs for the treatment of cancer
WO2002017911A1 (en) * 2000-08-30 2002-03-07 Teijin Limited Parathyroid hormone production inhibitors containing vitamin d3 derivatives
JP2005500289A (ja) 2001-06-13 2005-01-06 マグナケム インターナショナル ラボラトリーズ， インコーポレイテッド ラクトン処方物および使用方法
AU2008202109B2 (en) * 2001-06-13 2012-02-02 Magnachem International Laboratories, Inc Lactone formulations and method of use
US20050101575A1 (en) * 2002-02-20 2005-05-12 Karuya Takenouchi Vitamin d3 derivatives and remedies using the same
US7163933B2 (en) * 2002-02-22 2007-01-16 Teijin Limited Treating agent for Paget's disease of bone
WO2004041217A2 (en) 2002-11-05 2004-05-21 Magnachem International Laboratories, Inc. Synthetic lactone formulations and method of use
KR101092277B1 (ko) 2003-01-30 2011-12-13 데이진 화-마 가부시키가이샤 비타민 ｄ3 락톤 유도체
CA2514575A1 (en) * 2003-01-31 2004-08-12 Teijin Pharma Limited Crystal of (23s)-1.alpha.-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same
WO2005102315A1 (en) 2004-04-23 2005-11-03 Magnachem International Laboratories, Inc. Synthetic lactone formulations for pain control
JP2012507010A (ja) 2008-10-24 2012-03-22 マグナケム インターナショナル ラボラトリーズ， インコーポレイテッド Ｒａｄ９と選択的に相互作用する化合物をスクリーニングするための方法
JPWO2010053165A1 (ja) 2008-11-04 2012-04-05 帝人ファーマ株式会社 ビタミンｄ３ラクタム誘導体
KR101666255B1 (ko) * 2013-01-08 2016-10-13 삼성에스디아이 주식회사 이차 전지

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58118516A (ja) * 1981-12-29 1983-07-14 Teijin Ltd １α，２５−ジヒドロキシビタミンＤ↓３−２６，２３−ラクトンを含有するカルシユウム調節剤
JPS58210011A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
JPS60185715A (ja) * 1984-03-05 1985-09-21 Teijin Ltd 骨形成促進剤
CA2114830C (en) * 1993-02-05 2000-06-06 Masayasu Tabe Lactone compound and process of production thereof
EP0854139B1 (de) * 1994-06-07 2001-09-05 Teijin Limited Vitamin D3-Derivate und ein Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
ATE201397T1 (de) 2001-06-15
EP0854138A3 (de) 1998-09-23
EP0854138B1 (de) 2001-05-23
EP0854139B1 (de) 2001-09-05
EP0854139A2 (de) 1998-07-22
ATE186721T1 (de) 1999-12-15
US6177586B1 (en) 2001-01-23
US5719297A (en) 1998-02-17
DE69513367T2 (de) 2000-06-08
EP0712843A1 (de) 1996-05-22
DE69522589T2 (de) 2002-04-18
EP0854139A3 (de) 1998-09-23
EP0712843A4 (de) 1996-11-13
DE69522589D1 (de) 2001-10-11
DE69521065T2 (de) 2001-10-25
EP0854138A2 (de) 1998-07-22
DE69513367D1 (de) 1999-12-23
US5986112A (en) 1999-11-16
DE69521065D1 (de) 2001-06-28
WO1995033716A1 (en) 1995-12-14
ES2138212T3 (es) 2000-01-01
EP0712843B1 (de) 1999-11-17

Similar Documents

Publication Publication Date Title
ATE201397T1 (de) Vitamin d3 derivate und ein verfahren zu ihrer herstellung
ATE229960T1 (de) Verfahren zur herstellung von 13-ether-derivaten von milbemycinen und zwischenprodukte
ATE365171T1 (de) Verfahren zur herstellung einer epoxyverbindung
ATE121091T1 (de) Phospholipase a2-inhibitor, mikroorganismen, die diesen inhibitor erzeugen und mehrere verfahren zu seiner herstellung.
DE69717867D1 (de) Pyrazolopyridylpyrazinon-derivate und ein verfahren zu ihrer herstellung
DE69527400D1 (de) Wasserlösliche camptothecin-derivate, verfahren zu deren herstellung und deren verwendung als antitumor-mittel
KR960029336A (ko) 캄토테신 유도체, 그의 제조 방법 및 이를 함유하는 항암제
ATE157973T1 (de) Carbazolon - derivate und verfahren zu ihrer herstellung
ATE239701T1 (de) Polyethoxylierte retinamid-derivate und verfahren zu ihrer herstellung
NZ322318A (en) Method for preparing camptothecin derivatives
DE3483180D1 (de) Neue beta-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel (h).
DE69606411D1 (de) Verfahren zur herstellung von liponsaeure
ATE166060T1 (de) Neue (estradiol-derivat)-chlorambucil-konjugate, verfahren zu ihrer herstellung und pharmazeutische präparate
DE69704272D1 (de) Vitamin d analoga und verfahren zu ihrer herstellung
ATE5077T1 (de) 22-arylsulfonyl-24,25-dihydroxy-cholestane und verfahren zu ihrer herstellung.
DE69327906D1 (de) Vitamin-d-derivat und verfahren zu seiner herstellung
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
DE68907857D1 (de) Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3884518D1 (de) Naphthothiazepin-derivate und verfahren zu ihrer herstellung.
DE69719673D1 (de) D-pentofuranose-derivate und verfahren zu ihrer herstellung
ATE127774T1 (de) Verfahren zur herstellung von bicyclo(3.2.0)hept- 2-en-7-onen.
ATE94548T1 (de) Prostaglandin-vorlaeufer und ihre herstellung.
DE69302007D1 (de) Androst-4-en[4,5-b]-pyrrol-derivate und ein verfahren zu ihrer herstellung
DE59804539D1 (de) 15-methyl-cyclopropanosteroide und verfharen zu ihrer herstellung
ATE259821T1 (de) Oligosaccharide, verfahren zur ihrer herstellung und pharmazeutische zusammensetzung die sie enthalten